Advancing the standard of care in patients with type 2 diabetes and established cardiovascular disease: how can we improve patient outcomes? .

ESC Premium Access

Advancing the standard of care in patients with type 2 diabetes and established cardiovascular disease: how can we improve patient outcomes? .

Session: Reducing cardiovascular mortality in patients with type 2 diabetes: closing the gap between evidence and practice

Topic: Diabetes and the Heart

Speaker: Professor N. Marx (Aachen, DE) Professor D. McGuire (Dallas, US) Doctor J. Udell (Toronto, CA) Professor S. Verma (Toronto, CA) Professor N. Sattar (Glasgow, GB)

Sponsored by Boehringer Ingelheim & Eli Lilly and Company Diabetes Alliance

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speakers

Professor Nikolaus Marx

RWTH University Hospital Aachen, Aachen (Germany)

52 presentations

13 followers

Professor Darren Keith McGuire

University of Texas Southwestern Medical Center, Dallas (United States of America)

21 presentations

0 follower

Doctor Jacob Allan Udell

Women's College Hospital, Toronto (Canada)

9 presentations

0 follower

Professor Subodh Verma

St. Michael's Hospital, Toronto (Canada)

31 presentations

3 followers

Professor Naveed Sattar

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

43 presentations

5 followers

5 more presentations in this session

Welcome and introduction - Reducing cardiovascular mortality in patients with type 2 diabetes: closing the gap between evidence and practice.

Speaker: Professor N. Marx (Aachen, DE)

Access

Evidence-based approaches to reducing premature cardiovascular mortality in patients with type 2 diabetes and established cardiovascular disease.

Speaker: Professor D. McGuire (Dallas, US)

Access

Applying evidence in practice: appropriate use of empagliflozin in patients with type 2 diabetes and established cardiovascular disease in the cardiology clinic.

Speaker: Doctor J. Udell (Toronto, CA) Professor N. Sattar (Glasgow, GB)

Access

Exploring the effects of SGLT2 inhibition in ongoing trials.

Speaker: Professor S. Verma (Toronto, CA)

Access

Summary and close - Reducing cardiovascular mortality in patients with type 2 diabetes: closing the gap between evidence and practice.

Speaker: Professor N. Marx (Aachen, DE)

Access

Access the full session

Reducing cardiovascular mortality in patients with type 2 diabetes: closing the gap between evidence and practice

Speakers: Professor N. Marx, Professor D. McGuire, Doctor J. Udell, Professor S. Verma, Professor N. Sattar...

Access

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources